3,847
Views
24
CrossRef citations to date
0
Altmetric
Review Article

Toxicity of orally inhaled drug formulations at the alveolar barrier: parameters for initial biological screening

Pages 891-905 | Received 06 Apr 2017, Accepted 17 May 2017, Published online: 02 Jun 2017

References

  • Aggarwal NR , King LS , D’alessio FR. (2014). Diverse macrophage populations mediate acute lung inflammation and resolution. Am J Physiol Lung Cell Mol Physiol 306:L709–25.
  • Allavena P , Mantovani A. (2012). Immunology in the clinic review series; focus on cancer: tumour-associated macrophages: undisputed stars of the inflammatory tumour microenvironment. Clin Exp Immunol 167:195–205.
  • Arora D , Shah KA , Halquist MS , Sakagami M. (2010). In vitro aqueous fluid-capacity-limited dissolution testing of respirable aerosol drug particles generated from inhaler products. Pharm Res 27:786–95.
  • Bastacky J , Lee CY , Goerke J , et al . (1995). Alveolar lining layer is thin and continuous: low-temperature scanning electron microscopy of rat lung. J Appl Physiol 79:1615–28.
  • Boisa N , Elom N , Dean JR , et al . (2014). Development and application of an inhalation bioaccessibility method (IBM) for lead in the PM10 size fraction of soil. Environ Int 70:132–42.
  • Bonner JC. (2007). Lung fibrotic responses to particle exposure. Toxicol Pathol 35:148–53.
  • Boorsma CE , Draijer C , Melgert BN. (2013). Macrophage heterogeneity in respiratory diseases. Mediators Inflamm 2013:769214.
  • Börjel M , Sadler R , Gerde P. (2014). The dissolvIt: an in vitro evaluation of the dissolution and absorption of three inhaled dry powder drugs in the lung. Respiratory Drug Delivery to the Lungs Conference, Poster. Stockholm, Swedan: Karolinska Institutet.
  • Boyles MS , Young L , Brown DM , et al . (2015). Multi-walled carbon nanotube induced frustrated phagocytosis, cytotoxicity and pro-inflammatory conditions in macrophages are length dependent and greater than that of asbestos. Toxicol In Vitro 29:1513–28.
  • Brasey A , Igue R , Djemame L , et al . (2011). The effect of in vitro exposure to antisense oligonucleotides on macrophage morphology and function. J Nucleic Acids Invest 2:77–84.
  • Brown D , Kinloch I , Bangert U , et al . (2007). An in vitro study of the potential of carbon nanotubes and nanofibres to induce inflammatory mediators and frustrated phagocytosis. Carbon 45:1743–56.
  • Brown WJ , Sullivan TR , Greenspan P. (1992). Nile red staining of lysosomal phospholipid inclusions. Histochemistry 97:349–54.
  • Bzymek R , Horsthemke M , Isfort K , et al . (2016). Real-time two- and three-dimensional imaging of monocyte motility and navigation on planar surfaces and in collagen matrices: roles of Rho. Sci Rep 6:25016.
  • Campbell L , Abulrob AN , Kandalaft LE , et al . (2003). Constitutive expression of p-glycoprotein in normal lung alveolar epithelium and functionality in primary alveolar epithelial cultures. J Pharmacol Exp Ther 304:441–52.
  • Carlson GP. (2008). Critical appraisal of the expression of cytochrome P450 enzymes in human lung and evaluation of the possibility that such expression provides evidence of potential styrene tumorigenicity in humans. Toxicology 254:1–10.
  • Castell JV , Donato MT , Gomez-Lechon MJ. (2005). Metabolism and bioactivation of toxicants in the lung. The in vitro cellular approach. Exp Toxicol Pathol 57:189–204.
  • Castranova V , Rabovsky J , Tucker JH , Miles PR. (1988). The alveolar type II epithelial cell: a multifunctional pneumocyte. Toxicol Appl Pharmacol 93:472–83.
  • Cheng YS , Dahl AR , Jow HN. (1997). Dissolution of metal tritides in a simulated lung fluid. Health Phys 73:633–8.
  • Chitra S , Ganesan N , Lokeswari TS. (2014). Comparison of differentiation to macrophages in isolated monocytes from human peripheral blood and THP1 cells. Sri Ramacha J Med 7:1–7.
  • Cohen AJ , Bunn PA , Franklin W , et al . (1996). Neutral endopeptidase: variable expression in human lung, inactivation in lung cancer, and modulation of peptide-induced calcium flux. Cancer Res 56:831–9.
  • Colombo C , Monhemius AJ , Plant JA. (2008). Platinum, palladium and rhodium release from vehicle exhaust catalysts and road dust exposed to simulated lung fluids. Ecotoxicol Environ Saf 71:722–30.
  • Cook RO , Pannu RK , Kellaway IW. (2005). Novel sustained release microspheres for pulmonary drug delivery. J Control Release 104:79–90.
  • Courcot E , Leclerc J , Lafitte JJ , et al . (2012). Xenobiotic metabolism and disposition in human lung cell models: comparison with in vivo expression profiles. Drug Metab Dispos 40:1953–65.
  • Crabbe A , Sarker SF , Van Houdt R , et al . (2011). Alveolar epithelium protects macrophages from quorum sensing-induced cytotoxicity in a three-dimensional co-culture model. Cell Microbiol 13:469–81.
  • Crapo JD , Barry BE , Gehr P , et al . (1982). Cell number and cell characteristics of the normal human lung. Am Rev Respir Dis 126:332–7.
  • Daigneault M , Preston JA , Marriott HM , et al . (2010). The identification of markers of macrophage differentiation in PMA-stimulated THP-1 cells and monocyte-derived macrophages. PLoS One 5:e8668.
  • Davies NM , Feddah MR. (2003). A novel method for assessing dissolution of aerosol inhaler products. Int J Pharm 255:175–87.
  • Dean PJ , Groshart KD , Porterfield JG , et al . (1987). Amiodarone-associated pulmonary toxicity. A clinical and pathologic study of eleven cases. Am J Clin Pathol 87:7–13.
  • Ehrhardt C , Forbes B , Kim K. 2008. In vitro models of the Tracheo-Bronchial epithelium. In: Ehrhardt C & Kim K , eds. Drug absorption studies. New York: Springer; 235–57.
  • Ekwall B , Silano V , Paganuzzi-Stammati A , Zucco F. 1990. Toxicity tests with mammalian cell cultures. In: Bourdeau P , Somers E , Richardson G & Hickman J , eds. Short-term toxicity tests for non-genotoxiceEffects. Chichester: John Wiley & Sons Ltd.
  • El-Sherbiny I , Villanueva D , Herrera D , Smyth H. 2011. Overcoming lung clearance mechanisms for controlled release drug delivery. In: Smyth H & Hickey AJ , eds. Controlled pulmonary drug delivery. New York: Springer; 101–26.
  • Evans CM , Koo JS. (2009). Airway mucus: the good, the bad, the sticky. Pharmacol Ther 121:332–48.
  • Ferin J. (1982). Alveolar macrophage mediated pulmonary clearance suppressed by drug-induced phospholipidosis. Exp Lung Res 4:1–10.
  • Fernandes CA , Vanbever R. (2009). Preclinical models for pulmonary drug delivery. Expert Opin Drug Deliv 6:1231–45.
  • Ferreira PG , Costa S , Dias N , et al . (2014). Simultaneous interstitial pneumonitis and cardiomyopathy induced by venlafaxine. J Bras pneumol 40:313–8.
  • Fick RB, Jr ., Paul ES , Merrill WW , et al . (1984). Alterations in the antibacterial properties of rabbit pulmonary macrophages exposed to wood smoke. Am Rev Respir Dis 129:76–81.
  • Finch G. 2006. Nonclinical pharmacology and safety studies of insulin administered to the respiratory tract. In : H. Salem & S. Katz , eds. Inhal toxicol. Boca Raton: CRC Press; 609–22.
  • Forbes B , O’lone R , Allen PP , et al . (2014). Challenges for inhaled drug discovery and development: induced alveolar macrophage responses. Adv Drug Deliv Rev 71:15–33.
  • Foster KA , Avery ML , Yazdanian M , Audus KL. (2000). Characterization of the Calu-3 cell line as a tool to screen pulmonary drug delivery. Int J Pharm 208:1–11.
  • Fröhlich E , Meindl C. 2015. In vitro assessment of chronic nanoparticle effects on respiratory cells. In: Soloneski S & Larramendy M , eds. Nanomaterials – toxicity and risk assessment. Rijeka: InTech; 69–91.
  • Fröhlich E , Meindl C , Roblegg E , et al . (2012). Action of polystyrene nanoparticles of different sizes on lysosomal function and integrity. Part Fibre Toxicol 9:26.
  • Fröhlich E , Mercuri A , Wu S , Salar-Behzadi S. (2016). Measurements of deposition, lung surface area and lung fluid for simulation of inhaled compounds. Front Pharmacol 7:181.
  • Fröhlich E , Roblegg E. 2014. Mucus as physiological barrier to intracellular delivery. In: Prokop A , Iwasaki Y & Harada A , eds. Intracellular delivery fundamentals and applications. Dordrecht: Springer Science + Business Media; 139–63.
  • Fröhlich E , Salar-Behzadi S. (2014). Toxicological assessment of inhaled nanoparticles: role of in vivo, ex vivo, in vitro, and in silico studies. Int J Mol Sci 15:4795–822.
  • Fröhlich E , Samberger C , Kueznik T , et al . (2009). Cytotoxicity of nanoparticles independent from oxidative stress. J Toxicol Sci 34:363–75.
  • Gantt KR , Goldman TL , Mccormick ML , et al . (2001). Oxidative responses of human and murine macrophages during phagocytosis of Leishmania chagasi. J Immunol 167:893–901.
  • Garcia-Canton C , Minet E , Anadon A , Meredith C. (2013). Metabolic characterization of cell systems used in in vitro toxicology testing: lung cell system BEAS-2B as a working example. Toxicol In Vitro 27:1719–27.
  • Geiser M. (2002). Morphological aspects of particle uptake by lung phagocytes. Microsc Res Tech 57:512–22.
  • Geiser M. (2010). Update on macrophage clearance of inhaled micro- and nanoparticles. J Aerosol Med Pulm Drug Deliv 23:207–17.
  • Genin M , Clement F , Fattaccioli A , et al . (2015). M1 and M2 macrophages derived from THP-1 cells differentially modulate the response of cancer cells to etoposide. BMC Cancer 15:577.
  • Goerke J. (1998). Pulmonary surfactant: functions and molecular composition. Biochim Biophys Acta 1408:79–89.
  • Gonzalez-Rothi RJ , Zander DS , Ros PR. (1995). Fluoxetine hydrochloride (Prozac)-induced pulmonary disease. Chest 107:1763–5.
  • Gradon L , Podgorski A. (1995). Displacement of alveolar macrophages in air space of human lung. Med Biol Eng Comput 33:575–81.
  • Gray JE , Plumlee GS , Morman SA , et al . (2010). In vitro studies evaluating leaching of mercury from mine waste calcine using simulated human body fluids. Environ Sci Technol 44:4782–8.
  • Green FH , Schnürch S , Amrein M , et al . 2010. The role of surfactant in particle exposure. In: Gehr P , Mühlfeld C , Rothen-Rutishauser B & Blank F , eds. Particle-lung interactions. Boca Raton: Taylor & Francis Group; 204–25.
  • Gu BJ , Sun C , Fuller S , et al . (2014). A quantitative method for measuring innate phagocytosis by human monocytes using real-time flow cytometry. Cytometry A 85:313–21.
  • Harishchandra RK , Saleem M , Galla HJ. (2010). Nanoparticle interaction with model lung surfactant monolayers. J R Soc Interface 7:S15–S26.
  • Harkema J. 2000. Comparative structure of the respiratory tract: airway architecture in humans and animals. In: Cohen M , Zelikoff J & Schlesinger R , eds. Pulmonary immunotoxicology. Dordrecht: Kluwer Academic Publishers Group; 1–53.
  • Hassan NF , Campbell DE , Douglas SD. (1986). Purification of human monocytes on gelatin-coated surfaces. J Immunol Methods 95:273–6.
  • Hiemstra P. 2010. Host defense against infection in the airways. In Sethi S , ed. Respiratory infections. Boca Raton: CRC Press.
  • Hodge S , Hodge G , Ahern J , et al . (2007). Smoking alters alveolar macrophage recognition and phagocytic ability: implications in chronic obstructive pulmonary disease. Am J Respir Cell Mol Biol 37:748–55.
  • Hoffman E , Kumar A , Kanabar V , et al . (2015). In Vitro Multiparameter Assay Development Strategy toward Differentiating Macrophage Responses to Inhaled Medicines. Mol Pharm 12:2675–87.
  • Hofmann W , Asgharian B. (2002). Comparison of mucociliary clearance velocities in human and rat lungs for extrapolation modeling. Ann Occup Hyg 46:323–5.
  • Hofmann W , Koblinger L , Martonen TB. (1989). Structural differences between human and rat lungs: implications for Monte Carlo modeling of aerosol deposition. Health Phys 57:41–6. discussion 46-7.
  • Hopkins PM , Kermeen F , Duhig E , et al . (2010). Oil red O stain of alveolar macrophages is an effective screening test for gastroesophageal reflux disease in lung transplant recipients. J Heart Lung Transplant 29:859–64.
  • Horalkova L , Radziwon A , Endter S , et al . (2009). Characterisation of the R3/1 cell line as an alveolar epithelial cell model for drug disposition studies. Eur J Pharm Sci 36:444–50.
  • Hruban Z. (1984). Pulmonary and generalized lysosomal storage induced by amphiphilic drugs. Environ Health Perspect 55:53–76.
  • Huang LK , Tsai MJ , Tsai HC , et al . (2013). Statin-induced lung injury: diagnostic clue and outcome. Postgrad Med J 89:14–9.
  • Huaringa AJ , Francis WH. (2016). Pulmonary alveolar proteinosis: a case report and world literature review. Respirol Case Rep 4:e00201.
  • Hukkanen J , Pelkonen O , Hakkola J , Raunio H. (2002). Expression and regulation of xenobiotic-metabolizing cytochrome P450 (CYP) enzymes in human lung. Crit Rev Toxicol 32:391–411.
  • Hukkanen J , Vaisanen T , Lassila A , et al . (2003). Regulation of CYP3A5 by glucocorticoids and cigarette smoke in human lung-derived cells. J Pharmacol Exp Ther 304:745–52.
  • Ishii Y , Hashizume Y , Watanabe T , et al . (1991). Cysteine proteinases in bronchoalveolar epithelial cells and lavage fluid of rat lung. J Histochem Cytochem 39:461–8.
  • Israel-Biet D , Venet A , Caubarrere I , et al . (1987). Bronchoalveolar lavage in amiodarone pneumonitis. Cellular abnormalities and their relevance to pathogenesis. Chest 91:214–21.
  • Jaspart S , Bertholet P , Piel G , et al . (2007). Solid lipid microparticles as a sustained release system for pulmonary drug delivery. Eur J Pharm Biopharm 65:47–56.
  • Jensen B , Reiners M , Wolkenhauer M , et al . (2011). Dissolution testing for inhaled products. RDD Europe 2:303–8.
  • Jones BM , Nicholson JK , Holman RC , Hubbard M. (1989). Comparison of monocyte separation methods using flow cytometric analysis. J Immunol Methods 125:41–7.
  • Juillerat-Jeanneret L , Aubert JD , Leuenberger P. (1997). Peptidases in human bronchoalveolar lining fluid, macrophages, and epithelial cells: dipeptidyl (amino)peptidase IV, aminopeptidase N, and dipeptidyl (carboxy)peptidase (angiotensin-converting enzyme). J Lab Clin Med 130:603–14.
  • Julien C , Esperanza P , Bruno M , Alleman LY. (2011). Development of an in vitro method to estimate lung bioaccessibility of metals from atmospheric particles. J Environ Monit 13:621–30.
  • Kanapilly GM , Raabe OG , Goh CH , Chimenti RA. (1973). Measurement of in vitro dissolution of aerosol particles for comparison to in vivo dissolution in the lower respiratory tract after inhalation. Health Phys 24:497–507.
  • Kapellos TS , Taylor L , Lee H , et al . (2016). A novel real time imaging platform to quantify macrophage phagocytosis. Biochem Pharmacol 116:107–19.
  • Kasper M , Lackie P , Haase M , et al . (1996). Immunolocalization of cathepsin D in pneumocytes of normal human lung and in pulmonary fibrosis. Virchows Arch 428:207–15.
  • Knust J , Ochs M , Gundersen HJ , Nyengaard JR. (2009). Stereological estimates of alveolar number and size and capillary length and surface area in mice lungs. Anat Rec (Hoboken) 292:113–22.
  • Kotani N , Hashimoto H , Sessler DI , et al . (2000). Smoking decreases alveolar macrophage function during anesthesia and surgery. Anesthesiology 92:1268–77.
  • Kreyling W. (1990). Interspecies comparison of lung clearance of “Insoluble” particles. J Aerosol Med 3:S93–S110.
  • Lai SK , Wang YY , Wirtz D , Hanes J. (2009). Micro- and macrorheology of mucus. Adv Drug Deliv Rev 61:86–100.
  • Lankoff A , Sandberg WJ , Wegierek-Ciuk A , et al . (2012). The effect of agglomeration state of silver and titanium dioxide nanoparticles on cellular response of HepG2, A549 and THP-1 cells. Toxicol Lett 208:197–213.
  • Lapinsky SE , Mullen JB , Balter MS. (1993). Rapid pulmonary phospholipid accumulation induced by intravenous amiodarone. Can J Cardiol 9:322–4.
  • Lauffenburger DA , Linderman JL. 1993. Receptor-mediated cell behavioral responses. In: Lauffenburger DA & Linderman JL , eds. Receptors: models for binding, trafficking, and signaling. New York: Oxford University Press.
  • Liao X , Wiedmann TS. (2003). Solubilization of cationic drugs in lung surfactant. Pharm Res 20:1858–63.
  • Llinas A , Box K , Comer J , et al . (2014). Study of the impact on physicochemical properties of inhaled products in several simulated lung fluid media. AAPS Annual Meeting Exposition; T3057; San Diego, CA.
  • Loira-Pastoriza C , Todoroff J , Vanbever R. (2014). Delivery strategies for sustained drug release in the lungs. Adv Drug Deliv Rev 75:81–91.
  • Lundborg M , Dahlen SE , Johard U , et al . (2006). Aggregates of ultrafine particles impair phagocytosis of microorganisms by human alveolar macrophages. Environ Res 100:197–204.
  • Lynch T , Price A. (2007). The effect of cytochrome P450 metabolism on drug response, interactions, and adverse effects. Am Fam Physician 76:391–6.
  • Mahavadi P , Knudsen L , Venkatesan S , et al . (2015). Regulation of macroautophagy in amiodarone-induced pulmonary fibrosis. J Pathol Clin Res 1:252–63.
  • Mansour HM , Rhee YS , Wu X. (2009). Nanomedicine in pulmonary delivery. Int J Nanomedicine 4:299–319.
  • Marketsandmarkets (2017). North American Drug Delivery Technologies Market 2017 [online]. Available from: http://www.beforeitsnews.com [Accessed 11/02/2017]
  • May S , Jensen B , Weiler C , et al . (2014). Dissolution testing of powders for inhalation:iInfluence of particle deposition and modeling of dissolution profiles. Pharm Res 31:3211–24.
  • May S , Jensen B , Wolkenhauer M , et al . (2012). Dissolution techniques for in vitro testing of dry powders for inhalation. Pharm Res 29:2157–66.
  • Mcelroy MC , Kasper M. (2004). The use of alveolar epithelial type I cell-selective markers to investigate lung injury and repair. Eur Respir J 24:664–73.
  • Meindl C , Kueznik T , Bosch M , et al . (2015a). Intracellular calcium levels as screening tool for nanoparticle toxicity. J Appl Toxicol 35:1150–9.
  • Meindl C , Stranzinger S , Dzidic N , et al . (2015b). Permeation of therapeutic drugs in different formulations across the airway epithelium in vitro . PLoS One 10:e0135690.
  • Mercuri A , Wu S , Stranzinger S , et al . (2016). In vitro and in silico characterisation of Tacrolimus released under biorelevant conditions. Int J Pharm 515:271–80.
  • Mia S , Warnecke A , Zhang XM , et al . (2014). An optimized protocol for human M2 macrophages using M-CSF and IL-4/IL-10/TGF-beta yields a dominant immunosuppressive phenotype. Scand J Immunol 79:305–14.
  • Miller FJ. (2000). Dosimetry of particles in laboratory animals and humans in relationship to issues surrounding lung overload and human health risk assessment: a critical review. Inhal Toxicol 12:19–57.
  • Molina SA , Stauffer B , Moriarty HK , et al . (2015). Junctional abnormalities in human airway epithelial cells expressing F508del CFTR. Am J Physiol Lung Cell Mol Physiol 309:L475–87.
  • Morrow PE. (1988). Possible mechanisms to explain dust overloading of the lungs. Fundam Appl Toxicol 10:369–84.
  • Moss OR. (1979). Simulants of lung interstitial fluid. Health Phys 36:447–8.
  • Moss OR , Wong VA. (2006). When nanoparticles get in the way: impact of projected area on in vivo and in vitro macrophage function. Inhal Toxicol 18:711–6.
  • Murty VL , Sarosiek J , Slomiany A , Slomiany BL. (1984). Effect of lipids and proteins on the viscosity of gastric mucus glycoprotein. Biochem Biophys Res Commun 121:521–9.
  • Myrdal PB , Sheth P , Stein SW. (2014). Advances in metered dose inhaler technology: formulation development. AAPS PharmSciTech 15:434–55.
  • Nacca N , Bhamidipati CM , Yuhico LS , et al . (2012). Severe amiodarone induced pulmonary toxicity. J Thorac Dis 4:667–70.
  • National Research Council U. 1977. Respiratory transport and absorption. In: National Academy of Science, ed. Ozone and other photochemical oxidants. Washington, DC: National Research Council.
  • Ng SF , Rouse J , Sanderson D , Eccleston G. (2010). A comparative study of transmembrane diffusion and permeation of Ibuprofen across synthetic membranes using Franz diffusion cells. Pharmaceutics 2:209–23.
  • Nichols A. (2007). High content screening as a screening tool in drug discovery. Methods Mol Biol 356:379–87.
  • Niles AL , Moravec RA , Riss TL. (2009). In vitro viability and cytotoxicity testing and same-well multi-parametric combinations for high throughput screening. Curr Chem Genomics 3:33–41.
  • Nonoyama T , Fukuda R. (2008). Drug-induced phospholipidosis pathological aspects andiIts Prediction. J Toxicol Pathol 21:9–24.
  • Okumura K , Iwakawa S , Yoshida T , et al . (1992). Intratracheal delivery of insulin Absorption from solution and aerosol by rat lung. Int J Pharm 88:63–73.
  • Olsson B , Bondesson E , Borgström L , et al . 2011. Pulmonary Drug Metabolism, Clearence, and Absorption. In: Smyth H & Hickey A , eds. Controlled pulmonary drug delivery. New York: Springer; 21–50.
  • Parra E , Perez-Gil J. (2015). Composition, structure and mechanical properties define performance of pulmonary surfactant membranes and films. Chem Phys Lipids 185:153–75.
  • Patil JS , Sarasija S. (2012). Pulmonary drug delivery strategies: a concise, systematic review. Lung India 29:44–9.
  • Patton JS , Byron PR. (2007). Inhaling medicines: delivering drugs to the body through the lungs. Nat Rev Drug Discov 6:67–74.
  • Patton JS , Fishburn CS , Weers JG. (2004). The lungs as a portal of entry for systemic drug delivery. Proc Am Thorac Soc 1:338–44.
  • Patton JS , Mccabe JG , Hansen SE , Daugherty AL. (1989). Absorption of human growth hormone from the rat lung. Biotechnol Ther 1:213–28.
  • Pollmacher J , Figge MT. (2015). Deciphering chemokine properties by a hybrid agent-based model of Aspergillus fumigatus infection in human alveoli. Front Microbiol 6:503.
  • Prietl B , Meindl C , Roblegg E , et al . (2014). Nano-sized and micro-sized polystyrene particles affect phagocyte function. Cell Biol Toxicol 30:1–16.
  • Ramsey BW , Pepe MS , Quan JM , et al . (1999). Intermittent administration of inhaled tobramycin in patients with cystic fibrosis. Cystic Fibrosis Inhaled Tobramycin Study Group. N Engl J Med 340:23–30.
  • Reasor MJ , Mccloud CM , Dimatteo M , et al . (1996). Effects of amiodarone-induced phospholipidosis on pulmonary host defense functions in rats. Proc Soc Exp Biol Med 211:346–52.
  • Renwick LC , Donaldson K , Clouter A. (2001). Impairment of alveolar macrophage phagocytosis by ultrafine particles. Toxicol Appl Pharmacol 172:119–27.
  • Ribero R , Ferreira I , Figueiredo I , Vericimo M. (2015). Access to the tracheal pulmonary pathway in small rodents. J Bras Patol Med Lab 51:183–8.
  • Riley T , Christopher D , Arp J , et al . (2012). Challenges with developing in vitro dissolution tests for orally inhaled products (OIPs). AAPS PharmSciTech 13:978–89.
  • Rodero MP , Poupel L , Loyher PL , et al . (2015). Immune surveillance of the lung by migrating tissue monocytes. Elife 4:e07847.
  • Salama RO , Traini D , Chan HK , et al . (2009). Preparation and evaluation of controlled release microparticles for respiratory protein therapy. J Pharm Sci 98:2709–17.
  • Salama RO , Traini D , Chan HK , Young PM. (2008). Preparation and characterisation of controlled release co-spray dried drug-polymer microparticles for inhalation 2: evaluation of in vitro release profiling methodologies for controlled release respiratory aerosols. Eur J Pharm Biopharm 70:145–52.
  • Satoh T , Kidoya H , Naito H , et al . (2013). Critical role of Trib1 in differentiation of tissue-resident M2-like macrophages. Nature 495:524–8.
  • Schurch S , Qanbar R , Bachofen H , Possmayer F. (1995). The surface-associated surfactant reservoir in the alveolar lining. Biol Neonate 67:61–76.
  • Schwaiblmair M , Behr W , Haeckel T , et al . (2012). Drug induced interstitial lung disease. Open Respir Med J 6:63–74.
  • Schwaiblmair M , Berghaus T , Haeckel T , et al . (2010). Amiodarone-induced pulmonary toxicity: an under-recognized and severe adverse effect? Clin Res Cardiol 99:693–700.
  • Sdraulig S , Franich R , Tinker RA , et al . (2008). In vitro dissolution studies of uranium bearing material in simulated lung fluid. J Environ Radioact 99:527–38.
  • Seymour S. 2006. Pulmonary Consultation [online]. http://www.accessdata.fda.gov/drugsatfda_docs/nda/2006/021868s000_MedR_P2.pdf [Accessed 11/02/2017]
  • Shapiro DL , Nardone LL , Rooney SA , et al . (1978). Phospholipid biosynthesis and secretion by a cell line (A549) which resembles type II aleveolar epithelial cells. Biochim Biophys Acta 530:197–207.
  • Shayman JA , Abe A. (2013). Drug induced phospholipidosis: an acquired lysosomal storage disorder. Biochim Biophys Acta 1831:602–11.
  • Simon R. 1992. The biology and biochemistry of pulmonary alveolar epithelial cells. In Parent R , ed. Treatise on pumonary toxicology comparative biology of the normal lung. Boca Raton: CRC Press; 545–64.
  • Somers GI , Lindsay N , Lowdon BM , et al . (2007). A comparison of the expression and metabolizing activities of phase I and II enzymes in freshly isolated human lung parenchymal cells and cryopreserved human hepatocytes. Drug Metab Dispos 35:1797–805.
  • Son Y , Horng M , Copley M , Mcconville J. (2010). Optimization of an in vitro dissolution test method for inhalation formulations. Dissolution Technol 17:6–13.
  • Son YJ , Mcconville JT. (2009). Development of a standardized dissolution test method for inhaled pharmaceutical formulations. Int J Pharm 382:15–22.
  • Stone KC , Mercer RR , Freeman BA , et al . (1992). Distribution of lung cell numbers and volumes between alveolar and nonalveolar tissue. Am Rev Respir Dis 146:454–6.
  • Stopford W , Turner J , Cappellini D , Brock T. (2003). Bioaccessibility testing of cobalt compounds. J Environ Monit 5:675–80.
  • Takaya M , Shinohara Y , Serita F , et al . (2006). Dissolution of functional materials and rare earth oxides into pseudo alveolar fluid. Ind Health 44:639–44.
  • Taunton A , Gunter M , Druschel G , Wood S. (2010). Geochemistry in the lung: reaction-path modeling and experimental examination of rock-forming minerals under physiologic conditions. Am Min 95:1624–35.
  • Taylor MK , Hickey AJ , Vanoort M. (2006). Manufacture, characterization, and pharmacodynamic evaluation of engineered ipratropium bromide particles. Pharm Dev Technol 11:321–36.
  • Tiwari G , Tiwari R , Sriwastawa B , et al . (2012). Drug delivery systems: an updated review. Int J Pharm Investig 2:2–11.
  • Tomashefski J , Farver C. 2008. Anatomy and histology of the lung. In: Tomashefski J , Cagle P , Farver C & Fraire A , eds. Dail and hammar’s pulmonary pathology: Volume I: Nonneoplastic lung disease. New York: Springer Science + Business Media LLC, 19–48.
  • Ungaro F , D’emmanuele Di Villa Bianca R , Giovino C , et al . (2009). Insulin-loaded PLGA/cyclodextrin large porous particles with improved aerosolization properties: in vivo deposition and hypoglycaemic activity after delivery to rat lungs. J Control Release 135:25–34.
  • Ursini CL , Cavallo D , Fresegna AM , et al . (2014). Differences in cytotoxic, genotoxic, and inflammatory response of bronchial and alveolar human lung epithelial cells to pristine and COOH-functionalized multiwalled carbon nanotubes. Biomed Res Int 2014:359506.
  • Van Der Deen M , De Vries EG , Timens W , et al . (2005). ATP-binding cassette (ABC) transporters in normal and pathological lung. Respir Res 6:59.
  • Vickers AE , Jimenez RM , Spaans MC , et al . (1997). Human and rat lung biotransformation of cyclosporin A and its derivatives using slices and bronchial epithelial cells. Drug Metab Dispos 25:873–80.
  • Vlahos R , Bozinovski S. (2014). Role of alveolar macrophages in chronic obstructive pulmonary disease. Front Immunol 5:435.
  • Vrbanac J , Slauter R. 2013. ADME in drug discovery. In Faqi A , ed. A comprehensive guide to toxicology in preclinical drug development. London: Academic Press; 3–31.
  • Walski M , Pokorski M , Antosiewicz J , et al . (2009). Pulmonary surfactant: ultrastructural features and putative mechanisms of aging. J Physiol Pharmacol 60:121–5.
  • Wang W , Zhou QT , Sun SP , et al . (2016). Effects of surface composition on the aerosolisation and dissolution of inhaled antibiotic combination powders consisting of colistin and rifampicin. AAPS J 18:372–84.
  • Wauthoz N , Amighi K. 2015. Formulation Strategies for Pulmonary Delivery of Poorly Soluble Drugs. In Nokhodchi A & Martin G , eds. Pulmonary drug delivery advances and challenges. Chichester: John Wiley & Sons.
  • Weagel E , Smith C , Liu P , et al . (2015). Macrophage polarization and its role in cancer. J Clin Cell Immunol 6:338.
  • Weidauer E , Lehmann T , Ramisch A , et al . (2004). Response of rat alveolar type II cells and human lung tumor cells towards oxidative stress induced by hydrogen peroxide and paraquat. Toxicol Lett 151:69–78.
  • Welty-Wolf KE , Simonson SG , Huang YC , et al . (1997). Aerosolized manganese SOD decreases hyperoxic pulmonary injury in primates. II. Morphometric analysis. J Appl Physiol 83:559–68.
  • Winterbottom C , Shah R , Patterson K , et al . 2014. Ambient Particulate Matter Is Associated With Functional Decline In Idiopathic Pulmonary Fibrosis. http://www.atsjournals.org/doi/abs/10.1164/ajrccm-conference.2014.189.1_MeetingAbstracts.A1501.
  • Wragg J , Klinck B. (2007). The bioaccessibility of lead from Welsh mine waste using a respiratory uptake test. J Environ Sci Health A Tox Hazard Subst Environ Eng 42:1223–31.
  • Yang W , Tam J , Miller DA , et al . (2008). High bioavailability from nebulized itraconazole nanoparticle dispersions with biocompatible stabilizers. Int J Pharm 361:177–88.
  • Yao W , Li K , Liao K. (2009). Macropinocytosis contributes to the macrophage foam cell formation in RAW264.7 cells. Acta Biochim Biophys Sin (Shanghai) 41:773–80.
  • Yayoi Y , Ohsawa Y , Koike M , et al . (2001). Specific localization of lysosomal aminopeptidases in type II alveolar epithelial cells of the rat lung. Arch Histol Cytol 64:89–97.
  • Yin L , Stearns R , Gonzalez-Flecha B. (2005). Lysosomal and mitochondrial pathways in H2O2-induced apoptosis of alveolar type II cells. J Cell Biochem 94:433–45.